Is the priority review voucher program stimulating new drug development for tropical diseases?

Congress created the tropical disease priority review voucher program to stimulate new drug development for tropical diseases. An analysis of the pharmaceutical pipeline indicates that the development of drugs for these tropical diseases has increased. However, the effects of the program are not uni...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerr, Kirk W., Henry, Thomas C., Miller, Kathleen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103519/
https://www.ncbi.nlm.nih.gov/pubmed/30092022
http://dx.doi.org/10.1371/journal.pntd.0006695
_version_ 1783349354804805632
author Kerr, Kirk W.
Henry, Thomas C.
Miller, Kathleen L.
author_facet Kerr, Kirk W.
Henry, Thomas C.
Miller, Kathleen L.
author_sort Kerr, Kirk W.
collection PubMed
description Congress created the tropical disease priority review voucher program to stimulate new drug development for tropical diseases. An analysis of the pharmaceutical pipeline indicates that the development of drugs for these tropical diseases has increased. However, the effects of the program are not uniform across all diseases, as malaria and tuberculosis have seen significant new drug development, while other diseases have not.
format Online
Article
Text
id pubmed-6103519
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-61035192018-09-15 Is the priority review voucher program stimulating new drug development for tropical diseases? Kerr, Kirk W. Henry, Thomas C. Miller, Kathleen L. PLoS Negl Trop Dis Research Article Congress created the tropical disease priority review voucher program to stimulate new drug development for tropical diseases. An analysis of the pharmaceutical pipeline indicates that the development of drugs for these tropical diseases has increased. However, the effects of the program are not uniform across all diseases, as malaria and tuberculosis have seen significant new drug development, while other diseases have not. Public Library of Science 2018-08-09 /pmc/articles/PMC6103519/ /pubmed/30092022 http://dx.doi.org/10.1371/journal.pntd.0006695 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Kerr, Kirk W.
Henry, Thomas C.
Miller, Kathleen L.
Is the priority review voucher program stimulating new drug development for tropical diseases?
title Is the priority review voucher program stimulating new drug development for tropical diseases?
title_full Is the priority review voucher program stimulating new drug development for tropical diseases?
title_fullStr Is the priority review voucher program stimulating new drug development for tropical diseases?
title_full_unstemmed Is the priority review voucher program stimulating new drug development for tropical diseases?
title_short Is the priority review voucher program stimulating new drug development for tropical diseases?
title_sort is the priority review voucher program stimulating new drug development for tropical diseases?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103519/
https://www.ncbi.nlm.nih.gov/pubmed/30092022
http://dx.doi.org/10.1371/journal.pntd.0006695
work_keys_str_mv AT kerrkirkw isthepriorityreviewvoucherprogramstimulatingnewdrugdevelopmentfortropicaldiseases
AT henrythomasc isthepriorityreviewvoucherprogramstimulatingnewdrugdevelopmentfortropicaldiseases
AT millerkathleenl isthepriorityreviewvoucherprogramstimulatingnewdrugdevelopmentfortropicaldiseases

Ejemplares similares